GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-7.3%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$227M
AUM Growth
+$227M
(-39%)
Cap. Flow
-$74.2M
Cap. Flow
% of AUM
-32.73%
Top 10 Holdings %
Top 10 Hldgs %
57.37%
Holding
63
New
13
Increased
10
Reduced
18
Closed
16
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$7.41M |
| 2 |
Mersana Therapeutics
MRSN
|
$7M |
| 3 |
Verastem
VSTM
|
$3.96M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$3.71M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$3.69M |
Top Sells
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$13.9M |
| 2 |
Amicus Therapeutics
FOLD
|
$12.2M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$12M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$8.98M |
| 5 |
Sarepta Therapeutics
SRPT
|
$8.39M |
Sector Composition
| 1 | Healthcare | 90.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Insmed
INSM
$28.8B
| – | – | -200,000 | Closed | -$4.78M |
|
52
Karyopharm Therapeutics
KPTI
$61.7M
| – | – | -50,500 | Closed | -$968K |
|
53
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
54
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
55
Sarepta Therapeutics
SRPT
$1.78B
| – | – | -65,000 | Closed | -$8.39M |
|
56
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
57
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – | 0 | – | – |
|
|
SPPI
58
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| – | – | -38,340 | Closed | -$140K |
|
|
AERI
59
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – | -575,000 | Closed | -$13.9M |
|
|
GBT
60
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – | -33,400 | Closed | -$2.66M |
|
|
CHMA
61
DELISTED
Chiasma, Inc. Common Stock
CHMA
| – | – | -425,000 | Closed | -$2.11M |
|
|
ARQL
62
DELISTED
Arqule Inc
ARQL
| – | – | -300,000 | Closed | -$5.99M |
|
|
BHVN
63
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – | -40,000 | Closed | -$2.18M |
|